Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT00259402
Eligibility Criteria:
Inclusion Criteria:
* ECOG 0-1
* Patients with histologically proven epidermoid carcinoma or adenocarcinoma of esophagus or stomach, with unresectable or metastatic disease;
* No previous treatment with chemotherapy or radiotherapy
* Measurable lesion (uni or bidimensional)
Exclusion Criteria:
* Creatinin clearance \<50 mL/min
* Total bilirubin \>1.5\*ULN (Upper Limit of Normal)
* AST/ALT \> 2.5\*ULN
* Total White Blood Cell \<1.500.000/mL
* Platelet count \<100.000.000/mL
* symptomatic sensitive peripheral neuropathy
* pregnant or breast-feeding women
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00259402
Study Brief:
Protocol Section:
NCT00259402